feed,title,long_url,short_url
Benzinga,"Serious Adverse Event Triggers FDA Clinical Hold On Sigilon Therapeutics' Hemophilia A Trial, Shares Drop",https://benzinga.com/general/biotech/21/07/21913044/serious-adverse-event-triggers-fda-clinical-hold-on-sigilon-therapeutics-hemophilia-a-trial-share,https://j.mp/3wrXtSj
Benzinga,"Galectin Therapeutics Stock Surges After Robust Data From Belapectin/Keytruda Combo In Melanoma, Head & Neck Cancer",https://benzinga.com/general/biotech/21/07/21913735/galectin-therapeutics-stock-surges-after-robust-data-from-belapectinkeytruda-combo-in-melanoma-he,https://j.mp/2TSx0jM
